Gas exchange response to short-acting β2-agonists in chronic obstructive pulmonary disease severe exacerbations

American Journal of Respiratory and Critical Care Medicine

Volumn 176, Issue 4, 2007, Pages 350-355

  Polverino, Eva ^a   Gómez, Federico P ^a   Manrique, Hernán ^a   Soler, Néstor ^a   Roca, Josep ^a   Barberà, Joan Albert ^a   Rodríguez Roisin, Roberto ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic obstructive pulmonary disease exacerbations and management; Pulmonary gas exchange; Short acting bronchodilators; Ventilation perfusion mismatching

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; SALBUTAMOL; SHORT ACTING DRUG; TERBUTALINE; THEOPHYLLINE;

ADULT; AGED; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONVALESCENCE; DISEASE EXACERBATION; HEART OUTPUT; HEMODYNAMICS; HOSPITALIZATION; HUMAN; LUNG GAS EXCHANGE; LUNG VENTILATION PERFUSION RATIO; PRIORITY JOURNAL; SPIROMETRY; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

ADRENERGIC BETA-AGONISTS; AGED; ALBUTEROL; CARDIAC OUTPUT; FEMALE; HOSPITALIZATION; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS; REST; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34547931700     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200612-1864OC     Document Type: Article

References (29)

1. Parker CM, Voduc N, Aaron SD, Webb KA, O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbation of COPD. Eur Respir J 2005;26:420-428.
2. Stevenson NJ, Walker PP, Costello RW, Calverley PM. Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1510-1516.
3. Barbera JA, Roca J, Ferrer A, Felez MA, Diaz O, Roger N, Rodriguez-Roisin R. Mechanisms of worsening gas exchange during acute exacerbations of chronic obstructive pulmonary disease. Eur Respir J 1997;10:1285-1291.
4. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:158-164.
5. Wagner PD, Rodriguez-Roisin R. Clinical advances in pulmonary gas exchange. Am Rev Respir Dis 1991;143:883-888.
6. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease-2006 Update. [Internet] [updated 2007 May 16] Available from: http://ajrccm.atsjournals.org/cgi/reprint/200703-456SOv1
7. National Institute for Clinical Excellence (NICE). Chronic obstructive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232.
8. Barbera JA, Peces-Barba G, Agusti AG, Izquierdo JL, Monso E, Montemayor T, Viejo JL. Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease [article in Spanish]. Arch Bronconeumol 2001;37:297-316.
9. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
10. Rodriguez-Roisin R. COPD exacerbations.5: management. Thorax 2006;61:535-544.
11. Bach PB, Brown C, Gelfand SE, McCrory DC. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001;134:600-620.
12. Karpel JP, Pesin J, Greenberg D, Gentry E. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. Chest 1990;98:835-839.
13. Bernasconi M, Brandolese R, Poggi R, Manzin E, Rossi A. Dose-response effects and time course of effects of inhaled fenoterol on respiratory mechanics and arterial oxygen tension in mechanically ventilated patients with chronic airflow obstruction. Intensive Care Med 1990;16:108-114.
14. Polverino E, Gómez FP, Rodríguez AC, Peña A, Valera JL, Soler N, Barberà JA, Roca JR, Rodríguez-Roisin R. Nebulized salbutamol transiently deteriorates pulmonary gas exchange in COPD exacerbations. Proc Am Thorac Soc. 2005;2:A406.
15. Polverino E, Gómez FP, Valera JL, Soler N, Roca J, Barberà JA, Rodriguez-Roisin R. Gas exchange response to nebulized salbutamol in exacerbations and stable COPD. Proc Am Thorac Soc. 2006;3:A721.
16. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S-401S.
17. Roca J, Burgos F, Barbera JA, Sunyer J, Rodriguez-Roisin R, Castellsague J, Sanchis J, Anto JM, Casan P, Clausen JL. Prediction equations for plethysmographic lung volumes. Respir Med 1998;92:454-460.
18. Roca J, Burgos F, Sunyer J, Saez M, Chinn S, Anto JM, Rodriguez-Roisin R, Quanjer PH, Nowak D, Burney P. References values for forced spirometry: Group of the European Community Respiratory Health Survey. Eur Respir J 1998;11:1354-1362.
19. Gabrijelcic J, Casas A, Rabinovich RA, Roca J, Barbera JA, Chung KF, Rodriguez-Roisin R. Formoterol protects against platelet-activating factor-induced effects in asthma. Eur Respir J 2004;23:71-75.
20. Roca J, Wagner PD. Contribution of multiple inert gas elimination technique to pulmonary medicine. 1: principles and information content of the multiple inert gas elimination technique. Thorax 1994;49:815-824.
21. Rodriguez-Roisin R, Ballester E, Roca J, Torres A, Wagner PD. Mechanisms of hypoxemia in patients with status asthmaticus requiring mechanical ventilation. Am Rev Respir Dis 1989;139:732-739.
22. Cardus J, Burgos F, Diaz O, Roca J, Barbera JA, Marrades RM, Rodriguez-Roisin R, Wagner PD. Increase in pulmonary ventilation-perfusion inequality with age in healthy individuals. Am J Respir Crit Care Med 1997;156:648-653.
23. Gale GE, Torre-Bueno JR, Moon RE, Saltzman HA, Wagner PD. Ventilation-perfusion inequality in normal humans during exercise at sea level and simulated altitude. J Appl Physiol 1985;58:978-988.
24. McDonald DM. The ultrastructure and permeability of tracheobronchial blood vessels in health and disease. Eur Respir J Suppl 1990;12:572s-585s.
25. Diaz O, Barbera JA, Marrades R, Chung KF, Roca J, Rodriguez-Roisin R. Inhibition of PAF-induced gas exchange defects by β-adrenergic agonists in mild asthma is not due to bronchodilation. Am J Respir Crit Care Med 1997;156:17-22.
26. Mendes ES, Campos MA, Wanner A. Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. Chest 2006;129:893-898. [Published erratum appears in Chest 130:308.].
27. Ringsted CV, Eliasen K, Andersen JB, Heslet L, Qvist J. Ventilation-perfusion distributions and central hemodynamics in chronic obstructive pulmonary disease:effects of terbutaline administration. Chest 1989;96:976-983.
28. Ballester E, Reyes A, Roca J, Guitart R, Wagner PD, Rodriguez-Roisin R. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 1989;44:258-267.
29. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991;143:138-143.